Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Short-term Investments (2022 - 2025)

Definitive Healthcare's Short-term Investments history spans 4 years, with the latest figure at $17.3 million for Q4 2025.

  • For Q4 2025, Short-term Investments rose 13820.97% year-over-year to $17.3 million; the TTM value through Dec 2025 reached $17.3 million, up 13820.97%, while the annual FY2025 figure was $17.3 million, 13820.97% up from the prior year.
  • Short-term Investments reached $17.3 million in Q4 2025 per DH's latest filing, up from $116000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $229.6 million in Q3 2023 to a low of $116000.0 in Q3 2025.
  • Average Short-term Investments over 4 years is $132.8 million, with a median of $144.3 million recorded in 2022.
  • The largest YoY upside for Short-term Investments was 13820.97% in 2025 against a maximum downside of 99.93% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $184.9 million in 2022, then decreased by 4.24% to $177.1 million in 2023, then tumbled by 99.93% to $124000.0 in 2024, then skyrocketed by 13820.97% to $17.3 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Short-term Investments are $17.3 million (Q4 2025), $116000.0 (Q3 2025), and $103.2 million (Q2 2025).